PharmaEssentia Corporation (6446.TW)

TWD 530.0

(-1.49%)

Total Debt Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual total debt in 2023 was 1.2 Billion TWD , down -23.5% from previous year.
  • PharmaEssentia Corporation's latest quarterly total debt in 2024 Q2 was 1.07 Billion TWD , down -5.02% from previous quarter.
  • PharmaEssentia Corporation reported annual total debt of 1.56 Billion TWD in 2022, up 192.52% from previous year.
  • PharmaEssentia Corporation reported annual total debt of 536.31 Million TWD in 2021, down -17.08% from previous year.
  • PharmaEssentia Corporation reported quarterly total debt of 1.07 Billion TWD for 2024 Q2, down -5.02% from previous quarter.
  • PharmaEssentia Corporation reported quarterly total debt of 791.46 Million TWD for 2023 Q3, up 3.6% from previous quarter.

Annual Total Debt Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Total Debt of PharmaEssentia Corporation (2023 - 2019)

Year Total Debt Total Debt Growth
2023 1.2 Billion TWD -23.5%
2022 1.56 Billion TWD 192.52%
2021 536.31 Million TWD -17.08%
2020 646.8 Million TWD 75.13%
2019 369.33 Million TWD 0.0%

Peer Total Debt Comparison of PharmaEssentia Corporation

Name Total Debt Total Debt Difference
Grape King Bio Ltd 192.92 Million TWD -522.135%
Standard Chem & Pharm CO., LTD. 1.08 Billion TWD -10.926%
Maywufa Company Ltd. 442.66 Million TWD -171.135%
ScinoPharm Taiwan, Ltd. 621.1 Million TWD -93.24%
Lotus Pharmaceutical Co., Ltd. 11.58 Billion TWD 89.64%
LIWANLI Innovation Co., Ltd. 2.63 Million TWD -45431.942%
YungShin Global Holding Corporation 1.23 Billion TWD 3.163%
PhytoHealth Corporation 28.11 Million TWD -4168.974%
SCI Pharmtech, Inc. 1.04 Billion TWD -15.132%
Formosa Laboratories, Inc. 4.06 Billion TWD 70.47%
Bora Pharmaceuticals Co., LTD. 5 Billion TWD 76.043%